8th November 2019 – The MEA
parenteral nutrition market is expected to display a CAGR of 7.1% in
the forthcoming period owing to variables such as increase in premature births,
vulnerability to malnutrition, and increasing prevalence of cancers. In
addition, existing malnourished children and premature neonates with a specific
need for parenteral nutrition propels the market growth in the near future.
With the rise in supply of parenteral nutrition, the regions have witnessed a
strong decline in the prevalence of chronic disease and malnourishment.
Driving factors responsible for MEA
parenteral nutrition market include decline in child mortality rate and
improved healthcare settings. Rise in improved birth rate with enhanced
nutrition levels is expected to bolster MEA market during the forecast period.
Malnutrition is one of the primary drivers for MEA parenteral nutrition
industry. Secondary drivers include prevalence of chronic conditions and
administration of important nutrients that help in maintaining energy, strength
and hydration level.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/mea-parenteral-nutrition-market/request-sample
Nutrient type for MEA parenteral
nutrition market includes single amino dose acid, trace elements, vitamins
& minerals, carbohydrates, and parenteral lipid emulsions. Simple dose
amino acid dominates the market segment in the forecast period owing to
substantial increase in supply of medical formulations.
Geographical segmentation for MEA
parenteral nutrition market include Saudi Arabia, Kuwait, Oman, Jordan,
Lebanon, and UAE. Saudi Arabia accounted for a significant market share in
2016followed by Kuwait, Oman, Jordan, and Lebanon. Rise in healthcare settings,
increase in awareness and rise in healthcare expenditure is likely to support
the market growth in MEA regions. Healthcare settings in UAE witnesses several
improvements resulting out of significant investments by local government.
The key players in the MEA parenteral
nutrition industry includes B. Braun Melsungen AG; Baxter; Fresenius Kabi AG;
Hospira Inc.; Qatar Pharma Factory; Pharmaceutical Solutions Industry; Kuwait
Saudi Pharmaceutical Industries Co.; Alfa Laboratories; and Well Pharma.
Get
in touch
At Million Insights, we work with the
aim to reach the highest levels of customer satisfaction. Our representatives
strive to understand diverse client requirements and cater to the same with the
most innovative and functional solutions.
For
More Information, Visit @ https://www.millioninsights.com
No comments:
Post a Comment